Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...
Taiwan-based Foresee Pharmaceuticals has announced that Foresee Pharmaceuticals USA Inc., the company's fully-owned US s...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulti...
Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana® I.V. Infusion 60...
Singapore-based Hyphens Pharma International has granted the rights to commercialise its innovative product, Cerapro®...
ScinoPharm Taiwan has announced a landmark achievement in the global pharmaceutical landscape, securing US Food and Drug...
Japan's Shionogi & Co. will acquire a newly established company that Tanabe Pharma Corporation will create to hold t...
China-based Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has announce...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...
French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and...
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy® pill,...
Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture ...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a collabo...
The healthcare industry in Asia Pacific (APAC), home to half the world's population, faces a dual reality: immense oppor...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the Board of Directors’ decision...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
Eli Lilly and Company has announced a plan to invest more than $6 billion in a new manufacturing facility in Huntsville,...
Singapore-based Zuellig Pharma, a leading healthcare solutions company in Asia, has expanded its partnership with H...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
